SBI Securities’s Mentari Therapeutics, Inc. Common Stock MTRI Stock Holding History
Bought
Maintained
Sold
Other funds holding MTRI
SFCM
SBI Securities's MTRI Position: Q3 2026 in Review
SBI Securities held its Mentari Therapeutics, Inc. Common Stock (MTRI) position steady in Q3 2026 at 30 shares worth $408. The position accounts for ﹤0.01% of the portfolio, ranked #3181.
SBI Securities first reported a position in MTRI in Q1 2025 and has held it in 7 quarters since. The position peaked at $975 in Q2 2025. 16 funds tracked by Wall St. Rank hold MTRI as of Q3 2026.
- SBI Securities held 30 shares of Mentari Therapeutics, Inc. Common Stock worth $408 as of Q3 2026.
- SBI Securities left its Mentari Therapeutics, Inc. Common Stock share count unchanged in Q3 2026.
- Mentari Therapeutics, Inc. Common Stock made up ﹤0.01% of SBI Securities's portfolio in Q3 2026, its #3181 holding.
- SBI Securities first reported a position in Mentari Therapeutics, Inc. Common Stock in Q1 2025 and has held it in 7 quarters since.
- SBI Securities's Mentari Therapeutics, Inc. Common Stock position peaked at $975 in Q2 2025.
- 16 funds tracked by Wall St. Rank held Mentari Therapeutics, Inc. Common Stock as of Q3 2026.
Based on SBI Securities's 13F filing for Q3 2026, filed 22 Oct 2026.